FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 40 filers reported holding FATE THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $768,000 | +76.1% | 246,126 | -4.0% | 0.07% | +34.0% |
| Q2 2016 | $436,000 | -2.9% | 256,426 | +2.8% | 0.05% | -13.1% |
| Q1 2016 | $449,000 | -62.0% | 249,374 | -28.8% | 0.06% | -47.0% |
| Q4 2015 | $1,181,000 | -30.1% | 350,306 | +10.5% | 0.12% | -22.3% |
| Q3 2015 | $1,690,000 | -14.5% | 317,088 | +3.8% | 0.15% | +5.7% |
| Q2 2015 | $1,976,000 | – | 305,481 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $34,095 | 9.92% |
| Redmile Group, LLC | 12,957,222 | $130,738,370 | 5.35% |
| GCM Grosvenor Holdings, LLC | 1,037,256 | $10,465,913 | 2.67% |
| Casdin Capital, LLC | 2,050,000 | $20,684,500 | 1.60% |
| DAFNA Capital Management LLC | 550,940 | $5,558,985 | 1.57% |
| Artal Group S.A. | 2,600,000 | $26,234 | 1.46% |
| Monaco Asset Management SAM | 250,000 | $2,522,500 | 0.76% |
| Parametrica Management Ltd | 32,254 | $325,443 | 0.67% |
| Boxer Capital, LLC | 1,250,000 | $12,612,500 | 0.66% |
| Bellevue Group AG | 4,861,279 | $49,050,305 | 0.65% |